Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Predictors of disease activity in 857 patients with MS treated with interferon beta-1b.
Safety and efficacy of fingolimod in treatment-naïve multiple sclerosis patients.
Acute relapse after initiation of Siponimod in a patient with secondary progressive MS.
Evaluation of oxidative and nitrosative stress in relapsing remitting multiple sclerosis: effect of corticosteroid therapy.
Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: Relationship to oxidative stress.
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy.
Interpretation and visualization of non-linear data fusion in kernel space: study on metabolomic characterization of progression of multiple sclerosis.
Regression-Based Norms Improve the Sensitivity of the National MS Society Consensus Neuropsychological Battery for Pediatric Multiple Sclerosis (NBPMS).
Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity.
CCSVI and MS: no meaning, no fact.
Multiple sclerosis: a primary care perspective.
Recent Gains in Clinical Multiple Sclerosis Research Review.
The King-Devick (K-D) test of rapid eye movements: A bedside correlate of disability and quality of life in MS.
Administration of low dose-estrogen attenuates persistent inflammation, promotes angiogenesis and improves locomotor function following chronic spinal cord injury in rats.
2012 Annual Meeting: Primary Immune Deficiency Disease North American Conference
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study.
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.
Motor programme activating therapy influences adaptive brain functions in multiple sclerosis: clinical and MRI study.
Treatment of human spasticity with delta 9-tetrahydrocannabinol.
Client-centred therapy in multiple sclerosis: More intensive diagnostic evaluation and less intensive treatment.
Over six cups of coffee a day may reduce the risk of developing multiple sclerosis.
Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning.
Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain.
Acute disseminated encephalomyelitis in children: a single institution experience of 28 patients.
MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T.

Pages